RT期刊文章SR电子T1遵守预防HIV相关呼吸道疾病的指南JF欧洲呼吸杂志JO EUR呼吸J FD欧洲呼吸社会SP 2318 OP 2322 VO 9 IS 11 A1 MONTANER，JS A1 PHILLIPS，P PHILLIPS，P A1 ZALA，P A1 ZALA，c c a1 ZALA，C188bet官网地址A1 Craib，KJ A1 O'Shaughnessy，MV A1 Schechter，MT YR 1996 UL //www.qdcxjkg.com/content/9/9/11/2318.Abstract在这项研究中，我们表征了预防疗法的模式同性恋男性队列中的特定呼吸道疾病，并评估了有针对性的反馈对这些疾病指南的遵守程度的影响。所有人类免疫缺陷病毒血清神经（HIV-）（n = 169）并获得了免疫缺陷综合征（AIDS） - 无人免疫缺陷病毒血清阳性（HIV+）（n = 154）的参与者，他们在1989年10月和1989年10月之间完成四次访问确定了1993年12月。有关使用纯化蛋白衍生物（PPD）（结核蛋白）测试，肺炎球菌疫苗接种史，流感疫苗的史，使用肺炎孢子虫（PCP）预防，症状，症状和CD4计数的信息。1992年，为参与的医生提供了有关遵守当代预防呼吸道疾病指南的总体水平的反馈。作为本练习的一部分，对准则进行了分发和讨论。在研究期间，接受PPD测试的HIV+患者百分比从43％增加到65％（P = 0.001）。HIV+比HIV-患者进行了PPD检测明显多（P <0.001）。 A total of 144 (94%) HIV+ men received at least one influenza vaccination compared to 60 (35%) HIV- men (p<0.001). Utilization of influenza vaccination in the HIV+ group significantly increased from 78% in 1992 to 92% in 1993 (p<0.001). A total of 104 (68%) HIV+ men received pneumococcal vaccination compared to 2 (1%) HIV- men (p<0.001). Among HIV+ individuals whose absolute CD4+ count was less than 200 cells x mm(-3), the percentage of men who received primary PCP prophylaxis was 0, 86, 72 and 88 for the years 1990-1993, respectively. Among HIV+ patients whose only eligibility criterion for PCP prophylaxis was a CD4+ percentage <20%, compliance was 55, 30, 37 and 50% for the years 1990-1993, respectively. Among HIV+ subjects, increases in the compliance level were noted for all preventive therapies after targeted feedback was provided during the last quarter of 1992. However, only utilization of influenza vaccine exceeded a 90% compliance in 1993. These data demonstrate that a suboptimal level of compliance with current guidelines for the prevention of respiratory disease among human immunodeficiency virus-infected individuals can be significantly improved using targeted feedback. Although it is likely that similar effects could be achieved in other populations or the community at large, this remains to be demonstrated.